Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases-Reference-Cited by-同舟云学术

Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases

Published:2020-12-01 Issue:12 Volume:6 Page:1901
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Eitz Kerstin A.¹²,Lo Simon S.³,Soliman Hany⁴,Sahgal Arjun⁴,Theriault Aimee⁴,Pinkham Mark. B.⁵⁶,Foote Matthew C.⁵⁶,Song Andrew J.⁷,Shi Wenyin⁷,Redmond Kristin J.⁸,Gui Chenchen⁸,Kumar Aryavarta M. S.⁹,Machtay Mitchell¹⁰,Meyer Bernhard¹¹,Combs Stephanie E.¹²

Affiliation:

1. Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany

2. Institute for Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany

3. Department of Radiation Oncology, University of Washington, Seattle

4. Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada

5. Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia

6. Department of Radiation Oncology, University of Queensland, Brisbane, Queensland, Australia

7. Department of Radiation Oncology, Sidney Kimmel Medical College & Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania

8. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

9. Radiation Oncology Service, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio

10. Department of Radiation Oncology, University Hospital Cleveland Medical Center, Cleveland, Ohio

11. Department of Neurosurgery, Technical University of Munich (TUM), Munich, Germany

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2771754/jamaoncology_eitz_2020_oi_200075_1606943490.81368.pdf

Reference36 articles.

1. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.;Kocher;J Clin Oncol,2011

2. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).;Soffietti;Neuro Oncol,2017

3. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.;Mahajan;Lancet Oncol,2017

4. Comparison of local control of brain metastases with stereotactic radiosurgery vs surgical resection: a secondary analysis of a randomized clinical trial.;Churilla;JAMA Oncol,2019

5. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.;Brown;Lancet Oncol,2017

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a scoring system to predict local recurrence in brain metastases following complete resection and observation;Journal of Neuro-Oncology;2024-08-05

2. Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors;Clinical and Translational Radiation Oncology;2024-05

3. Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and Immunotherapy;International Journal of Radiation Oncology*Biology*Physics;2024-04

4. Hypofractionated Stereotactic Radiosurgery in the Management of Brain Metastases;Neurosurgery;2024-03-21

5. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer;Strahlentherapie und Onkologie;2024-03-15